Catalyst Wire Dossier Catalyst Wire Dossier

Ensitrelvir

ensitrelvir · Shionogi & Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ensitrelvir, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID [Phase 2]

See pricing